Parkside Financial Bank & Trust’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-80
Closed -$274 2709
2026
Q1
$274 Hold
80
﹤0.01% 2626
2025
Q4
$227 Hold
80
﹤0.01% 2632
2025
Q3
$557 Hold
80
﹤0.01% 2523
2025
Q2
$474 Buy
+80
New +$460 ﹤0.01% 2580

Other funds holding ASPN

Parkside Financial Bank & Trust's ASPN Position: Q2 2026 in Review

Parkside Financial Bank & Trust sold out of Aspen Aerogels (ASPN) in Q2 2026, closing a stake of 80 shares — an estimated $274 sold.

Parkside Financial Bank & Trust first reported a position in ASPN in Q2 2025 and held it in 4 quarters. The position peaked at $557 in Q3 2025. 179 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • Parkside Financial Bank & Trust reported no remaining Aspen Aerogels position as of Q2 2026 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 80 Aspen Aerogels shares in Q2 2026, an estimated $274.
  • Parkside Financial Bank & Trust first reported a position in Aspen Aerogels in Q2 2025 and held it in 4 quarters.
  • Parkside Financial Bank & Trust's Aspen Aerogels position peaked at $557 in Q3 2025.
  • 179 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.